{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:50:25Z","timestamp":1790297425203,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,19]]},"DOI":"10.7759\/cureus.92759","type":"journal-article","created":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T05:23:39Z","timestamp":1758345819000},"source":"Crossref","is-referenced-by-count":1,"title":["Mixed Aldosterone and Cortisol Secretion in Patients with Adrenal Incidentalomas: Different Faces of the Old Concept of Connshing Syndrome"],"prefix":"10.7759","author":[{"given":"Teodora","family":"Kamenova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aneliya","family":"Nankova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivesta","family":"Kirova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgi","family":"Kirilov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Zacharieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atanaska","family":"Elenkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(79)90803-9","article-title":"Concurrent hypersecretion of aldosterone and cortisol from the adrenal cortical adenoma","volume":"67","author":"Komiya I","year":"1979","unstructured":"Komiya I, Koizumi Y, Kobayashi R, Kotani M, Yamada T, Maruyama Y. Concurrent hypersecretion of aldosterone and cortisol from the adrenal cortical adenoma. Am J Med. 1979, 67:516-8. 10.1016\/0002-9343(79)90803-9","journal-title":"Am J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.93136","article-title":"Steroid metabolome analysis reveals prevalent glucocorticoid excess in primary aldosteronism","volume":"2","author":"Arlt W","year":"2017","unstructured":"Arlt W, Lang K, Sitch AJ, et al.. Steroid metabolome analysis reveals prevalent glucocorticoid excess in primary aldosteronism. JCI Insight. 2017, 2:93136. 10.1172\/jci.insight.93136","journal-title":"JCI Insight"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2007.33","article-title":"Cardiovascular outcomes in patients with primary aldosteronism after treatment","volume":"168","author":"Catena C","year":"2008","unstructured":"Catena C, Colussi G, Nadalini E, Chiuch A, Baroselli S, Lapenna R, Sechi LA. Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch Intern Med. 2008, 168:80-5. 10.1001\/archinternmed.2007.33","journal-title":"Arch Intern Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa606","article-title":"Evolution of the primary aldosteronism syndrome: updating the approach","volume":"105","author":"Vaidya A","year":"2020","unstructured":"Vaidya A, Carey RM. Evolution of the primary aldosteronism syndrome: updating the approach. J Clin Endocrinol Metab. 2020, 105:3771-83. 10.1210\/clinem\/dgaa606","journal-title":"J Clin Endocrinol Metab"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12112772","article-title":"The entity of Connshing syndrome: primary aldosteronism with autonomous cortisol secretion","volume":"12","author":"Carsote M","year":"2022","unstructured":"Carsote M. The entity of Connshing syndrome: primary aldosteronism with autonomous cortisol secretion. Diagnostics (Basel). 2022, 12:2772. 10.3390\/diagnostics12112772","journal-title":"Diagnostics (Basel)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2478\/s11536-013-0199-9","article-title":"Clinical characteristics and follow-up of incidentally found adrenal tumours - results from a single tertiary centre","volume":"9","author":"Vasilev V","year":"2014","unstructured":"Vasilev V, Matrozova J, Elenkova A, Zacharieva S. Clinical characteristics and follow-up of incidentally found adrenal tumours - results from a single tertiary centre. Cent Eur J Med. 2014, 9:292-301. 10.2478\/s11536-013-0199-9","journal-title":"Cent Eur J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society clinical practice guideline","volume":"101","author":"Funder JW","year":"2016","unstructured":"Funder JW, Carey RM, Mantero F, et al.. The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2016, 101:1889-916. 10.1210\/jc.2015-4061","journal-title":"J Clin Endocrinol Metab"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-16-0003","article-title":"A new highly sensitive and specific overnight combined screening and diagnostic test for primary aldosteronism","volume":"175","author":"Tsiavos V","year":"2016","unstructured":"Tsiavos V, Markou A, Papanastasiou L, et al.. A new highly sensitive and specific overnight combined screening and diagnostic test for primary aldosteronism. Eur J Endocrinol. 2016, 175:21-8. 10.1530\/EJE-16-0003","journal-title":"Eur J Endocrinol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/ejendo\/lvad066","article-title":"European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors","volume":"189","author":"Fassnacht M","year":"2023","unstructured":"Fassnacht M, Tsagarakis S, Terzolo M, et al.. European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol. 2023, 189:G1-G42. 10.1093\/ejendo\/lvad066","journal-title":"Eur J Endocrinol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-020-0490-0","article-title":"Clinical characterization of patients with primary aldosteronism plus subclinical Cushing's syndrome","volume":"20","author":"Yasuda S","year":"2020","unstructured":"Yasuda S, Hikima Y, Kabeya Y, et al.. Clinical characterization of patients with primary aldosteronism plus subclinical Cushing's syndrome. BMC Endocr Disord. 2020, 20:9. 10.1186\/s12902-020-0490-0","journal-title":"BMC Endocr Disord"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/ejendo\/lvaf007","article-title":"Mild autonomous cortisol secretion in patients with aldosterone-producing adenoma and risk for cardiac remodeling and diastolic dysfunction","volume":"192","author":"Tsai CH","year":"2025","unstructured":"Tsai CH, Liao CW, Wu XM, et al.. Mild autonomous cortisol secretion in patients with aldosterone-producing adenoma and risk for cardiac remodeling and diastolic dysfunction. Eur J Endocrinol. 2025, 192:81-90. 10.1093\/ejendo\/lvaf007","journal-title":"Eur J Endocrinol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e32834e90f0","article-title":"The history of primary hyperaldosteronism with simultaneous hypercortisolism","volume":"30","author":"Ferri C","year":"2012","unstructured":"Ferri C, Grassi D. The history of primary hyperaldosteronism with simultaneous hypercortisolism. J Hypertens. 2012, 30:432-3. 10.1097\/HJH.0b013e32834e90f0","journal-title":"J Hypertens"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-021-00818-2","article-title":"Concurrence of overt Cushing's syndrome and primary aldosteronism accompanied by aldosterone-producing cell cluster in adjacent adrenal cortex: case report","volume":"21","author":"Fushimi Y","year":"2021","unstructured":"Fushimi Y, Tatsumi F, Sanada J, et al.. Concurrence of overt Cushing's syndrome and primary aldosteronism accompanied by aldosterone-producing cell cluster in adjacent adrenal cortex: case report. BMC Endocr Disord. 2021, 21:163. 10.1186\/s12902-021-00818-2","journal-title":"BMC Endocr Disord"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-10-1070","article-title":"Aldosterone- and cortisol-co-secreting adrenal tumors: the lost subtype of primary aldosteronism","volume":"164","author":"Sp\u00e4th M","year":"2011","unstructured":"Sp\u00e4th M, Korovkin S, Antke C, Anlauf M, Willenberg HS. Aldosterone- and cortisol-co-secreting adrenal tumors: the lost subtype of primary aldosteronism. Eur J Endocrinol. 2011, 164:447-55. 10.1530\/EJE-10-1070","journal-title":"Eur J Endocrinol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaf284","article-title":"Primary aldosteronism: an Endocrine Society clinical practice guideline","volume":"110","author":"Adler GK","year":"2025","unstructured":"Adler GK, Stowasser M, Correa RR, et al.. Primary aldosteronism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2025, 110:2453-95. 10.1210\/clinem\/dgaf284","journal-title":"J Clin Endocrinol Metab"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.7326\/M17-0882","article-title":"The spectrum of subclinical primary aldosteronism and incident hypertension: a cohort study","volume":"167","author":"Brown JM","year":"2017","unstructured":"Brown JM, Robinson-Cohen C, Luque-Fernandez MA, et al.. The spectrum of subclinical primary aldosteronism and incident hypertension: a cohort study. Ann Intern Med. 2017, 167:630-41. 10.7326\/M17-0882","journal-title":"Ann Intern Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.124.073507","article-title":"Subclinical primary aldosteronism and major adverse cardiovascular events: a longitudinal population-based cohort study","author":"Goupil R","year":"2025","unstructured":"Goupil R, Desbiens LC, Merabtine A, et al.. Subclinical primary aldosteronism and major adverse cardiovascular events: a longitudinal population-based cohort study. Circulation. 2025, 10.1161\/CIRCULATIONAHA.124.073507","journal-title":"Circulation"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.13922","article-title":"Primary aldosteronism decreases insulin secretion and increases insulin clearance in humans","volume":"75","author":"Adler GK","year":"2020","unstructured":"Adler GK, Murray GR, Turcu AF, et al.. Primary aldosteronism decreases insulin secretion and increases insulin clearance in humans. Hypertension. 2020, 75:1251-9. 10.1161\/HYPERTENSIONAHA.119.13922","journal-title":"Hypertension"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/s41371-020-00467-3","article-title":"The mineralocorticoid receptor-an emerging player in metabolic syndrome?","volume":"35","author":"Thuzar M","year":"2021","unstructured":"Thuzar M, Stowasser M. The mineralocorticoid receptor-an emerging player in metabolic syndrome?. J Hum Hypertens. 2021, 35:117-23. 10.1038\/s41371-020-00467-3","journal-title":"J Hum Hypertens"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-13-0754","article-title":"Is diabetes in Cushing's syndrome only a consequence of hypercortisolism?","volume":"170","author":"Giordano C","year":"2014","unstructured":"Giordano C, Guarnotta V, Pivonello R, et al.. Is diabetes in Cushing's syndrome only a consequence of hypercortisolism?. Eur J Endocrinol. 2014, 170:311-9. 10.1530\/EJE-13-0754","journal-title":"Eur J Endocrinol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1159\/000314319","article-title":"Pathophysiology of diabetes mellitus in Cushing's syndrome","volume":"92 Suppl 1","author":"Pivonello R","year":"2010","unstructured":"Pivonello R, De Leo M, Vitale P, et al.. Pathophysiology of diabetes mellitus in Cushing's syndrome. Neuroendocrinology. 2010, 92 Suppl 1:77-81. 10.1159\/000314319","journal-title":"Neuroendocrinology"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2019-00299","article-title":"Impaired glucose metabolism in primary aldosteronism is associated with cortisol cosecretion","volume":"104","author":"Gerards J","year":"2019","unstructured":"Gerards J, Heinrich DA, Adolf C, et al.. Impaired glucose metabolism in primary aldosteronism is associated with cortisol cosecretion. J Clin Endocrinol Metab. 2019, 104:3192-202. 10.1210\/jc.2019-00299","journal-title":"J Clin Endocrinol Metab"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ando.2025.101706","article-title":"Co-existing autonomous cortisol secretion in primary aldosteronism","volume":"86","author":"Barlas T","year":"2025","unstructured":"Barlas T, Eroglu Altinova A, Balos Toruner F, Cerit ET, Yalcin MM, Karakoc A, Akturk M. Co-existing autonomous cortisol secretion in primary aldosteronism. Ann Endocrinol (Paris). 2025, 86:101706. 10.1016\/j.ando.2025.101706","journal-title":"Ann Endocrinol (Paris)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.108.122002","article-title":"Fasting plasma glucose and serum lipids in patients with primary aldosteronism: a controlled cross-sectional study","volume":"53","author":"Matrozova J","year":"2009","unstructured":"Matrozova J, Steichen O, Amar L, Zacharieva S, Jeunemaitre X, Plouin PF. Fasting plasma glucose and serum lipids in patients with primary aldosteronism: a controlled cross-sectional study. Hypertension. 2009, 53:605-10. 10.1161\/HYPERTENSIONAHA.108.122002","journal-title":"Hypertension"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.01.052","article-title":"Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice","volume":"69","author":"Monticone S","year":"2017","unstructured":"Monticone S, Burrello J, Tizzani D, et al.. Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice. J Am Coll Cardiol. 2017, 69:1811-20. 10.1016\/j.jacc.2017.01.052","journal-title":"J Am Coll Cardiol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.112.197111","article-title":"Observational study mortality in treated primary aldosteronism: the German Conn's registry","volume":"60","author":"Reincke M","year":"2012","unstructured":"Reincke M, Fischer E, Gerum S, et al.. Observational study mortality in treated primary aldosteronism: the German Conn's registry. Hypertension. 2012, 60:618-24. 10.1161\/HYPERTENSIONAHA.112.197111","journal-title":"Hypertension"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13891","article-title":"Primary aldosteronism is associated with decreased low-density and high-density lipoprotein particle concentrations and increased GlycA, a pro-inflammatory glycoprotein biomarker","volume":"90","author":"Berends AM","year":"2019","unstructured":"Berends AM, Buitenwerf E, Gruppen EG, et al.. Primary aldosteronism is associated with decreased low-density and high-density lipoprotein particle concentrations and increased GlycA, a pro-inflammatory glycoprotein biomarker. Clin Endocrinol (Oxf). 2019, 90:79-87. 10.1111\/cen.13891","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-92477-9","article-title":"The association between aldosterone and lipid profiles in patients with primary aldosteronism","volume":"15","author":"Liang NP","year":"2025","unstructured":"Liang NP, Rao KR, Hu M, et al.. The association between aldosterone and lipid profiles in patients with primary aldosteronism. Sci Rep. 2025, 15:8755. 10.1038\/s41598-025-92477-9","journal-title":"Sci Rep"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1093\/ejendo\/lvaf117","article-title":"Expert consensus on the Primary Aldosteronism Severity Classification and its strategic application in indicating adrenal venous sampling","volume":"193","author":"Murakami M","year":"2025","unstructured":"Murakami M, Naruse M, Kobayashi H, et al.. Expert consensus on the Primary Aldosteronism Severity Classification and its strategic application in indicating adrenal venous sampling. Eur J Endocrinol. 2025, 193:85-96. 10.1093\/ejendo\/lvaf117","journal-title":"Eur J Endocrinol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1093\/ejendo\/lvaf124","article-title":"A global real-world study assessing total time to adrenalectomy in primary aldosteronism","volume":"193","author":"Ter C","year":"2025","unstructured":"Ter C, Koh XH, Tran H, et al.. A global real-world study assessing total time to adrenalectomy in primary aldosteronism. Eur J Endocrinol. 2025, 193:65-75. 10.1093\/ejendo\/lvaf124","journal-title":"Eur J Endocrinol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/402571-mixed-aldosterone-and-cortisol-secretion-in-patients-with-adrenal-incidentalomas-different-faces-of-the-old-concept-of-connshing-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T05:23:40Z","timestamp":1758345820000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/402571-mixed-aldosterone-and-cortisol-secretion-in-patients-with-adrenal-incidentalomas-different-faces-of-the-old-concept-of-connshing-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,19]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.92759","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,19]]}}}